INJEKTORVORRICHTUNG

Patent europeic · EP3538184 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3538184
Numer da la dumonda
EP17783845
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
12-10-2017
Publitgà
18-09-2019
Concedì
23-07-2025
La protecziun finescha il pli tard
11-10-2037
Proxima taxa annuala scadenta
31-10-2026
Classas IPC
A61M 5/315 (2006.01)
A61M 5/20 (2006.01)
Prioritad
EP 16197955 09.11.2016
Dumonda PCT
PCT/EP2017/076108 12.10.2017
Publicaziun PCT
WO2018/086817 17.05.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 04-06-2026

    Midada

    Published in Swissreg on 04.06.2026

  2. 22-12-2025

    Adressa dal possessur midada

    Owner
    Sanofi-Aventis Deutschland GmbH, Brüningstraße 50, Bldg. K703, Room 4071, 65926 Frankfurt am Main, Germany → Sanofi-Aventis Deutschland GmbH, Brüningstraße 50, 65929 Frankfurt am Main, Germany

    Published in Swissreg on 22.12.2025

  3. 01-11-2025

    Midada

    Published in Swissreg on 01.11.2025

  4. 23-07-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 23.07.2025

Partidas

Possessur

Sanofi-Aventis Deutschland GmbH

Brüningstraße 50, 65929 Frankfurt am Main, DE

Inventur

WILSON, Robbie

Melbourn Hertfordshire SG5 6DP, GB

SINGH, Harpal

Melbourn Hertfordshire SG5 6DP, GB

YOUNG, Matthew

Melbourn Hertfordshire SG5 6DP, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.